Africa CDC - LSHTM MRC International Statistics & Epidemiology Group Partnership to Support Robust Analysis of COVID-19 Seroprevalence Data in Africa

点击翻译按钮获取中文摘要

Africa Centres for Disease Control and Prevention (Africa CDC) is supporting African Union Member States to conduct national surveys to determine the percentage of people who have antibodies against SARS-CoV-2, the virus that causes COVID-19. Seventeen countries have completed or are currently conducting the first round of these surveys, and they have agreed to share their data to enable combined analysis. This project will employ a medical statistician to manage and analyse this complex multi-country COVID-19 survey data, advise country-level teams on survey design and analysis issues, and finalise the database so that it can be used for future research. The results of these time-critical analyses will be used to inform rapid response prevention planning, policy, and practice at country and continental level. In addition, the statistician will provide on-the-job training and mentoring to Africa CDC staff, strengthening institutional capacity to conduct statistical analyses and interpret findings. They will initially be employed for six months, but further funding will be identified to extend the duration of the post and to ensure sustainable strengthening of biostatistical capacity at Africa CDC.